FDA Approves Orforglipron, First GLP-1 Pill Without Time, Food, or Water Restrictions

Pharmacy Times·Apr 1

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

The FDA has approved orforglipron, also known as Foundayo, a daily pill for weight loss that can be taken at any time without restrictions on food or water. This medication is reportedly the first oral GLP-1 receptor agonist approved for weight loss with no such restrictions. The approval marks a new development in the treatment of obesity, with orforglipron being described as an oral alternative to existing treatments.

Full coverage

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

2 Minute Medicine·4d ago

FDA Approves Orforglipron (Foundayo) As First Daily GLP-1 Pill Without Food, Water Restrictions

HCP Live·Apr 1

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

PR Newswire·Apr 1

FDA Approves Orforglipron, First Oral GLP-1 Receptor Agonist for Weight Loss With No Food or Water Restrictions

Patient Care Online·Apr 1

Fetching the latest headlines…

FDA Approves Orforglipron, First GLP-1 Pill Without Time, Food, or Water Restrictions

Full coverage

Foundayo (Orforglipron) Approval Marks the Beginning of the Oral GLP-1 Era for Obesity Treatment

FDA Approves Orforglipron (Foundayo) As First Daily GLP-1 Pill Without Food, Water Restrictions

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions

FDA Approves Orforglipron, First Oral GLP-1 Receptor Agonist for Weight Loss With No Food or Water Restrictions

FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic

FDA Approves Eli Lilly's Obesity Pill, Foundayo

New GLP-1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity

FDA Approves New Weight-Loss Pill That Can Be Taken Any Time of Day